⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Official Title: A Phase II, Multicentre, Non-Comparative, Open-Label Study To Evaluate The Efficacy And Tolerability Of ZD1839 (Iressa™) In Asymptomatic Radio-Naive Patients With Brain Metastases From Non-Small Cell Lung Carcinoma (NSCLC) Who Have Relapsed Following Prior Chemotherapy

Study ID: NCT00234442

Interventions

Iressa (Gefitinib)

Study Description

Brief Summary: The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, Bologna, , Italy

Research Site, Orbassano, , Italy

Research Site, Parma, , Italy

Research Site, Rozzano, , Italy

Contact Details

Name: Lucio Crino, MD

Affiliation: Bologna, Italy

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: